MANFREDI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 377
EU - Europa 225
NA - Nord America 219
SA - Sud America 55
AF - Africa 4
Totale 880
Nazione #
SG - Singapore 197
US - Stati Uniti d'America 194
IT - Italia 93
CN - Cina 85
BR - Brasile 45
HK - Hong Kong 38
DE - Germania 33
SE - Svezia 23
VN - Vietnam 17
CA - Canada 15
FI - Finlandia 14
GB - Regno Unito 14
JP - Giappone 11
NL - Olanda 11
IN - India 10
AT - Austria 8
MX - Messico 8
AR - Argentina 7
FR - Francia 6
RU - Federazione Russa 6
ES - Italia 4
PL - Polonia 4
ZA - Sudafrica 4
BD - Bangladesh 3
BE - Belgio 3
IE - Irlanda 3
IL - Israele 3
UZ - Uzbekistan 3
CH - Svizzera 2
ID - Indonesia 2
IR - Iran 2
PK - Pakistan 2
TR - Turchia 2
TW - Taiwan 2
CO - Colombia 1
DO - Repubblica Dominicana 1
GY - Guiana 1
JM - Giamaica 1
LT - Lituania 1
PE - Perù 1
Totale 880
Città #
Singapore 164
Ashburn 45
Hong Kong 37
Milan 28
Beijing 19
Dallas 19
Shanghai 17
Rome 14
Hefei 13
Munich 13
New York 13
Turku 9
Los Angeles 8
Cesano Boscone 7
Nuremberg 7
São Paulo 7
Tokyo 7
Denver 6
Houston 6
Amsterdam 5
Montreal 5
Moscow 5
Poplar 5
Vienna 5
Bergamo 4
Boardman 4
Chicago 4
Guangzhou 4
Helsinki 4
Ho Chi Minh City 4
Johannesburg 4
Lawrence 4
Ottawa 4
Princeton 4
Warsaw 4
Brussels 3
Cantù 3
Dublin 3
Frankfurt am Main 3
Hanoi 3
Ibaraki 3
Kfar Saba 3
Monza 3
Mumbai 3
Neu-Ulm 3
Querétaro 3
Santa Clara 3
Tashkent 3
Toronto 3
Ankara 2
Atlanta 2
Basel 2
Benxi 2
Boston 2
Brescia 2
Brooklyn 2
Burolo 2
Chaoyang 2
Chennai 2
Falkenstein 2
Freiburg im Breisgau 2
Genoa 2
Hải Dương 2
London 2
Manchester 2
Mexico City 2
Montes Claros 2
New Taipei City 2
North Bergen 2
Orem 2
Pittsburgh 2
Pune 2
Romagnano Sesia 2
San Francisco 2
Shijiazhuang 2
Stockholm 2
Trento 2
Vancouver 2
Washington 2
Albany 1
Aracaju 1
Araraquara 1
Baltimore 1
Belo Horizonte 1
Bismarck 1
Biên Hòa 1
Blumenau 1
Brasília 1
Brāhmanbāria 1
Cabo Frio 1
Caruaru 1
Catania 1
Central 1
Charleston 1
Charlotte 1
Chivilcoy 1
Contagem 1
Cusco 1
Cândido Mota 1
Córdoba 1
Totale 631
Nome #
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 99
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 94
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 83
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 82
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 75
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 70
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 69
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 62
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 60
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 56
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 54
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 49
Totale 909
Categoria #
all - tutte 5.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/202222 0 0 0 1 0 0 0 4 8 1 3 5
2022/202349 8 8 5 2 4 6 1 2 6 3 1 3
2023/202453 0 0 4 11 6 8 0 7 2 1 5 9
2024/2025285 12 5 8 9 16 28 53 52 18 25 24 35
2025/2026499 73 46 24 134 205 17 0 0 0 0 0 0
Totale 909